Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (SHA:603168)

SHA:603168 Revenue

Zhejiang Shapuaisi Pharmaceutical had revenue of 97.98M CNY in the quarter ending June 30, 2026, a decrease of -27.07%. This brings the company's total for the last twelve months to 423.20M, down -12.42% year-over-year. In the year 2025, Zhejiang Shapuaisi Pharmaceutical had annual revenue of 462.78M, down -4.38%. That makes Zhejiang Shapuaisi Pharmaceutical the 26,146th largest company in the world by revenue and 4,614th in China.

• Revenue (ttm): 423.20M
• Revenue Growth: -12.42%
• P/S Ratio: 5.00
• Revenue / Employee: 370.58K
• Employees: 1,142
• Market Cap: 2.12B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Sale of Merchandise 312.77M 71.2%
• Medical Service 126.60M 28.8%

Fiscal year ended Dec 31, 2025 See the full SHA:603168 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	462.78M	-21.18M	-4.38%
Dec 31, 2024	483.96M	-161.01M	-24.96%
Dec 31, 2023	644.97M	95.43M	17.37%
Dec 31, 2022	549.54M	-80.23M	-12.74%
Dec 31, 2021	629.76M	282.96M	81.59%

Data Source: S&P Global Market Intelligence Last updated: Aug 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error